Researchers no difference between subcutaneous IV infliximab in IBD - Healio

SAN DIEGO — Subcutaneous infliximab maintained remission among patients with inflammatory bowel disease who switched from IV dosing, according to research presented at Digestive Disease Week.“A subcutaneous (SC) formulation of infliximab (IFX) has…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio SAN DIEGO — Subcutaneous infliximab main… [+2444 chars]

full article...